Загрузка...
Predicted savings to the UK National Health Service from switching to generic antiretrovirals, 2014–2018
INTRODUCTION: In other disease areas, generic drugs are normally used after patent expiry. Patents on zidovudine, lamivudine, nevirapine and efavirenz have already expired. Patents will expire for abacavir in late 2014, lopinavir/r in 2016, and tenofovir, darunavir and atazanavir in 2017. However, p...
Сохранить в:
| Опубликовано в: : | J Int AIDS Soc |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
International AIDS Society
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4224875/ https://ncbi.nlm.nih.gov/pubmed/25394006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19497 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|